0001127602-20-005477.txt : 20200214 0001127602-20-005477.hdr.sgml : 20200214 20200214122448 ACCESSION NUMBER: 0001127602-20-005477 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200213 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERTOLINI ROBERT J CENTRAL INDEX KEY: 0001270263 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 20616765 MAIL ADDRESS: STREET 1: C/O SCHERING PLOUGH CORP STREET 2: 2000 GALLOPING HILL RD CITY: KENILWORTH STATE: NJ ZIP: 070333 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-02-13 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001270263 BERTOLINI ROBERT J CHARLES RIVER LABORATORIES 251 BALLARDVALE STREET WILMINGTON MA 01887 1 Common Stock 2020-02-13 4 M 0 4030 43.39 A 31905 D Common Stock 2020-02-13 4 M 0 3140 70.29 A 35045 D Common Stock 2020-02-13 4 S 0 7170 170.4071 D 27875 D Stock Options (Right to Buy) 43.39 2020-02-13 4 M 0 4030 0 D 2014-05-08 2020-05-08 Common Stock 4030 0 D Stock Options (Right to Buy) 70.29 2020-02-13 4 M 0 3140 0 D 2016-05-06 2020-05-06 Common Stock 3140 0 D This transaction was executed in multiple trades at prices ranging from $169.925 to $170.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Robert J. Bertolini 2020-02-14